Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 3/2017

01-03-2017 | Head and Neck Oncology

Comparison of Salvage Total Pharyngolaryngectomy and Cervical Esophagectomy Between Hypopharyngeal Cancer and Cervical Esophageal Cancer

Authors: Katsushi Takebayashi, MD, PhD, Yasuhiro Tsubosa, MD, PhD, Tomoyuki Kamijo, MD, PhD, Yoshiyuki Iida, MD, Atsushi Imai, MD, PhD, Masato Nagaoka, MD, Takashi Kitani, MD, Masahiro Niihara, MD, PhD, Eisuke Booka, MD, PhD, Ayako Shimada, MD, Masahiro Nakagawa, MD, PhD, Tetsuro Onitsuka, MD, PhD

Published in: Annals of Surgical Oncology | Issue 3/2017

Login to get access

Abstract

Background

Total pharyngolaryngectomy and cervical esophagectomy (TPLCE) after chemoradiotherapy remains a challenge because of the high rate of complications and few available data on outcomes and safety. The purpose of this study was to evaluate the clinical significance of salvage TPLCE and to compare treatment outcomes between hypopharyngeal cancer and cervical esophageal cancer.

Methods

Data from 37 consecutive patients who were diagnosed with potentially resectable hypopharyngeal and cervical esophageal cancer after chemoradiotherapy were retrospectively analyzed. The survival and surgical outcomes were investigated between the hypopharyngeal cancer and cervical esophageal cancer groups.

Results

Twenty-six patients were included in hypopharyngeal cancer group and 11 patients were included in cervical esophageal cancer group. The baseline characteristics were balanced between the two groups. Compared to the hypopharyngeal cancer group, the cervical esophageal cancer group had significantly more frequent tracheal-related complications (p < 0.05) and stronger association of distal margin of the cervical esophagus and radiation field with tracheal ischemia after salvage surgery.

Conclusions

Salvage TPLCE can offer the exclusive chance of prolonged survival. Association of tracheal ischemia with salvage TPLCE was seen more frequently for cervical esophageal cancer. Therefore, the indication for salvage TPLCE must be carefully considered to maintain the balance between curability and safety.
Literature
1.
Gkika E, Gauler T, Eberhardt W, Stahl M, Stuschke M, Pottgen C. Long-term results of definitive radiochemotherapy in locally advanced cancers of the cervical esophagus. Dis Esophagus. 2013;27:678–84.CrossRefPubMed
2.
Suzuki K, Hayashi R, Ebihara M, et al. The effectiveness of chemoradiation therapy and salvage surgery for hypopharyngeal squamous cell carcinoma. Jpn J Clin Oncol. 2013;43:1210–7.CrossRefPubMed
3.
Tsou YA, Hua CH, Lin MH, Tseng HC, Tsai MH, Shaha A. Comparison of pharyngocutaneous fistula between patients followed by primary laryngopharyngectomy and salvage laryngopharyngectomy for advanced hypopharyngeal cancer. Head Neck. 2010;32:1494–500.CrossRefPubMed
4.
Dirven R, Swinson BD, Gao K, Clark JR. The assessment of pharyngocutaneous fistula rate in patients treated primarily with definitive radiotherapy followed by salvage surgery of the larynx and hypopharynx. Laryngoscope. 2009;119:1691–5.CrossRefPubMed
5.
Mendenhall WM, Sombeck MD, Parsons JT Kasper ME, Stringer SP, Vogel SB. Management of cervical esophageal carcinoma. Semin Radiat Oncol. 1994;4:179–91.CrossRefPubMed
6.
Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer. 2005;114:806–16.CrossRefPubMed
7.
Saeki H, Tsutsumi S, Yukaya T, et al. Clinicopathological features of cervical esophageal cancer: retrospective analysis of 63 consecutive patients who underwent surgical resection. Ann Surg. 2016. In press.
8.
Miyamoto S, Sakuraba M, Nagamatsu S, Hayashi R. Salvage total pharyngolaryngectomy and free jejunum transfer. Laryngoscope. 2001;121:947–51.CrossRef
9.
Kadota H, Fukushima J, Nakashima T et al. Comparison of salvage and planned pharyngolaryngectomy with jejunal transfer for hypopharyngeal carcinoma after chemoradiotherapy. Laryngoscope. 2010;120:1103–8.PubMed
10.
Chang DW, Hussussian C, Lewin JS, Youssef AA, Robb GL, Reece GP. Analysis of pharyngocutaneous fistula following free jejunal transfer for total laryngopharyngectomy. Plast Reconstr Surg. 2002;109:1522–7.CrossRefPubMed
11.
McCaffrey TV, Fisher J. Effect of radiotherapy on the outcome of pharyngeal reconstruction using free jejunal transfer. Ann Otol Rhinol Laryngol. 1987;96:22–5.CrossRefPubMed
12.
Japanese Research Society for Esophageal Diseases. Japanese classification of esophageal cancer. 2nd English ed. Tokyo: Kanehara; 2008.
13.
Japan Society for Head and Neck Cancer. General rules for clinical studies on head and neck cancer. 5th ed. Tokyo: Kanehara; 2012. pp. 58–65.
14.
Mayanagi S, Onitsuka T, Nakagawa M, Sato H, Kitagawa Y, Tsubosa Y. The use of short segment free jejunal transfer as salvage surgery for cervical esophageal and hypopharyngeal cancer. World J Surg. 2014;38:144–9.CrossRefPubMed
15.
Ajani JA, Bentrem DJ, Besh S, et al. Esophageal and esophagogastric junction cancers (excluding the proximal 5 cm of the stomach). National Comprehensive Cancer Network clinical practice guidelines in oncology. 2015;13(2):194–227.
16.
Teoh AY, Chiu PW, Yeung WK, Liu SY, Wong SK, Ng EK. Longterm survival outcomes after definitive chemoradiation versus surgery in patients with resectable squamous carcinoma of the esophagus: results from a randomized controlled trial. Ann Oncol. 2013;24:165–71.CrossRefPubMed
17.
Bedenne L, Michel P, Bouché O, et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol. 2007;25:1160–8.CrossRefPubMed
18.
Wakui R, Yamashita H, Okuma K, et al. Esophageal cancer: definitive chemoradiotherapy for elderly patients. Dis Esophagus. 2010;23:572–9.CrossRefPubMed
19.
Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trials (RTOG 85-01)—radiation therapy oncology group. JAMA. 1999;281:1623–7.CrossRefPubMed
20.
Minsky BD, Pajak TF, Ginsberg RJ, et al. INT 0123 (radiation therapy oncology group 94-05) phase III trial of combined modality therapy for esophageal cancer: high-dose versus standard dose radiation therapy. J Clin Oncol. 2002;20:1167–74.CrossRefPubMed
21.
Brockstein B, Haraf DJ, Rademaker AW et al. Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience. Ann Oncol. 2004;15:1179–86.CrossRefPubMed
22.
Salama JK, Seiwert TY, Vokes EE. Chemoradiotherapy for locally advanced head and neck cancer. J Clin Oncol. 2007;25:4118–26.CrossRefPubMed
23.
Takeuchi S, Ohtsu A, Doi T, et al. A retrospective study of definitive chemoradiotherapy for elderly patients with esophageal cancer. Am J Clin Oncol. 2007;30:607–11.CrossRefPubMed
24.
Gardner-Thorpe J, Hardwick RH, Dwerryhouse SJ. Salvage oesophagectomy after local failure of definitive chemoradiotherapy. Br J Surg. 2007;94:1059–66.CrossRefPubMed
25.
Fujiki M, Miyamoto S, Sakuraba M, Nagamatsu S, Hayashi R. Risk factors for tracheal necrosis after total pharyngolaryngectomy. Head Neck. 2015;37:1207–10.CrossRefPubMed
26.
Salassa JR, Pearson BW, Payne WS. Gross and microscopical blood supply of the trachea. Ann Thorac Surg. 1977;24:100–7.CrossRefPubMed
27.
Booka E, Tsubosa Y, Niihara M, et al. Risk factors for complications after pharyngolaryngectomy with total esophagectomy. Esophagus. 2016. In press.
28.
Markar S, Gronnier C, Duhamel A, et al. Salvage surgery after chemoradiotherapy in the management of esophageal cancer: is it a viable therapeutic option? J Clin Oncol. 2015;33:3866–73.CrossRefPubMed
Metadata
Title
Comparison of Salvage Total Pharyngolaryngectomy and Cervical Esophagectomy Between Hypopharyngeal Cancer and Cervical Esophageal Cancer
Authors
Katsushi Takebayashi, MD, PhD
Yasuhiro Tsubosa, MD, PhD
Tomoyuki Kamijo, MD, PhD
Yoshiyuki Iida, MD
Atsushi Imai, MD, PhD
Masato Nagaoka, MD
Takashi Kitani, MD
Masahiro Niihara, MD, PhD
Eisuke Booka, MD, PhD
Ayako Shimada, MD
Masahiro Nakagawa, MD, PhD
Tetsuro Onitsuka, MD, PhD
Publication date
01-03-2017
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 3/2017
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-016-5474-y

Other articles of this Issue 3/2017

Annals of Surgical Oncology 3/2017 Go to the issue

Breast Oncology

The Impact of Primary Care Providers on Patient Screening Mammography and Initial Presentation in an Underserved Clinical Setting

Translational Research and Biomarkers

Attenuated RND1 Expression Confers Malignant Phenotype and Predicts Poor Prognosis in Hepatocellular Carcinoma

Gastrointestinal Oncology

The Preoperative Frailty Versus Inflammation-Based Prognostic Score: Which is Better as an Objective Predictor for Gastric Cancer Patients 80 Years and Older?

Reconstructive Oncology

Prior Radiotherapy Does Not Affect Abdominal Wall Reconstruction Outcomes: Evidence from Propensity Score Analysis

Gastrointestinal Oncology

Esophageal Cancer Surgery for Patients with Concomitant Liver Cirrhosis: A Single-Center Matched-Cohort Study

Thoracic Oncology

Clinical Significance of C-MET Overexpression and Epidermal Growth Factor Receptor Mutation in Platinum-Based Adjuvant Chemotherapy Outcome in Surgically Resected Lung Adenocarcinoma